AMPICILLIN AND SULBACTAM FOR INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of one unit of AMPICILLIN AND SULBACTAM FOR INJECTION at a unit price of $24.29, resulting in a total contract value of $24.29. The award was made on July 18, 2026, and delivery is required by July 20, 2026, to USS CHARLESTON LCS 18 at FPO AP 96694, with FOB Destination terms placing responsibility for shipping and risk on the contractor until receipt at the destination. The acquisition is governed under FAR Part 12 as a commercial item purchase, incorporating clauses 52.212-1, 52.212-4, and 52.212-5 by reference, with no alternate clauses or negotiated modifications indicated. The contractor is certified as a Women-Owned Small Business under NAICS code 325412 with a size standard of 1,300 employees and has affirmed the contract is a rated order under the Defense Priorities and Allocations System (DPAS), triggering priority performance obligations. Packaging and marking instructions require all shipments to be traceable, prohibit parcel post, and mandate labeling with the delivery order number SPE2DX-25-D-9822 in block printing, though no specific MIL-STD or barcoding standards are cited. Payment will be processed by DEF FIN AND ACCOUNTING SVC in Columbus, Ohio, leveraging a voucher-based system tied to the delivery order and stock requisition numbers, with Fast Pay Net 15 terms applicable due to the small business status. The contracting officer is Lisa Quinn, with Lorinda Ferraiolo as the signing authority, though no COR or COTR is designated. The award appears to be based on lowest price technically acceptable criteria, with no documented evaluation of non-price factors, consistent with the minimal value and commercial nature of the item. All required representations and certifications are included, and no pre-award survey was conducted.